Autologous stem cell transplantation is safe and effective for fit, older myeloma patients: exploratory results from the Myeloma XI trial

Autologous stem cell transplant (ASCT) remains the standard of care for consolidation after induction therapy for eligible patients with newly diagnosed myeloma. In recent clinical trials comparing ASCT to delayed ASCT, patients aged over 65 were excluded. In real-world practice stem cell transplant...

Descripción completa

Detalles Bibliográficos
Autores principales: Pawlyn, Charlotte, Cairns, David A., Menzies, Tom, Jones, John R., Jenner, Matthew W., Cook, Gordon, Boyd, Kevin D., Drayson, Mark T., Kaiser, Martin F., Owen, Roger G., Gregory, Walter, Morgan, Gareth J., Jackson, Graham H., Davies, Faith E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719065/
https://www.ncbi.nlm.nih.gov/pubmed/33297668
http://dx.doi.org/10.3324/haematol.2020.262360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719065/
https://www.ncbi.nlm.nih.gov/pubmed/33297668
http://dx.doi.org/10.3324/haematol.2020.262360

Ejemplares similares